LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting December 3, 2025 Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant Epilepsy
Titan Group: Financial Calendar 2026 November 26, 2025 Regulatory News: Titan S.A. (Euronext Brussels, ATHEX and Euronext Paris, TITC) announces its financial calendar for 2026. 19 March 2026 Publication of the fourth quarter and full year 2025 results 27 March 2026 Publication of the Integrated Annual Report 2025 7 May 2026 Publication of the first quarter 2026 results 7 May 2026 Annual General [...]